Back to top
more

Huntsman (HUN)

(Delayed Data from NYSE)

$9.36 USD

9.36
8,284,301

+0.15 (1.63%)

Updated Aug 4, 2025 04:00 PM ET

After-Market: $9.36 0.00 (0.00%) 7:50 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (233 out of 246)

Industry: Chemical - Diversified

Zacks News

Zacks Equity Research

Is the Options Market Predicting a Spike in Huntsman (HUN) Stock?

Investors need to pay close attention to Huntsman (HUN) stock based on the movements in the options market lately.

Zacks Equity Research

Huntsman (HUN) Down 4.5% Since Last Earnings Report: Can It Rebound?

Huntsman (HUN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Huntsman's Q3 Earnings Surpass Estimates, Revenues Miss

HUN's Q3 Polyurethanes sales increase is primarily driven by rising sales volumes, partly offset by reduced MDI prices.

Zacks Equity Research

Huntsman (HUN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Huntsman (HUN) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Equity Research

Huntsman (HUN) Beats Q3 Earnings Estimates

Huntsman (HUN) delivered earnings and revenue surprises of 11.11% and 0.69%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

FMC (FMC) Beats Q3 Earnings and Revenue Estimates

FMC (FMC) delivered earnings and revenue surprises of 40.82% and 3.39%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Earnings Preview: Innospec (IOSP) Q3 Earnings Expected to Decline

Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Earnings Preview: Huntsman (HUN) Q3 Earnings Expected to Decline

Huntsman (HUN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Here's Why You Should Retain Huntsman Stock in Your Portfolio

While HUN faces headwinds from soft demand in certain markets, it gains on actions to grow its downstream specialty and formulation businesses and acquisitions.

Zacks Equity Research

Huntsman (HUN) Up 3% Since Last Earnings Report: Can It Continue?

Huntsman (HUN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Huntsman Gains on Downstream Expansion Amid Demand & Pricing Woes

While HUN faces headwinds from soft demand conditions, it benefits from investment in downstream businesses and strategic acquisitions.

Zacks Equity Research

Here's Why You Should Hold Onto Huntsman (HUN) Stock for Now

While Huntsman (HUN) is exposed to challenges from soft demand in specific markets and pricing pressures, it gains on actions to grow its downstream specialty and formulation businesses and synergies of acquisitions.

Zacks Equity Research

Huntsman's (HUN) Q2 Earnings Beat Estimates, Revenues Miss

Huntsman's (HUN) second-quarter earnings beat estimates but sales miss the same on lower average selling prices.

Zacks Equity Research

Huntsman (HUN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Huntsman (HUN) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Equity Research

Huntsman (HUN) Surpasses Q2 Earnings Estimates

Huntsman (HUN) delivered earnings and revenue surprises of 16.67% and 2.83%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

LyondellBasell (LYB) Surpasses Q2 Earnings Estimates

LyondellBasell (LYB) delivered earnings and revenue surprises of 0.45% and 1.07%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Kronos Worldwide (KRO) Earnings Expected to Grow: What to Know Ahead of Q2 Release

Kronos Worldwide (KRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Earnings Preview: Huntsman (HUN) Q2 Earnings Expected to Decline

Huntsman (HUN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nilanjan Choudhury headshot

Sasol (SSL) Stock Loses 26% in 2024: Wish to Buy the Drop?

Sasol Limited's (SSL) focus on free cash flow generation, decarbonization, and operational enhancements positions it well for long-term growth.

Zacks Equity Research

Here's Why You Should Hold Onto Huntsman (HUN) Stock for Now

While Huntsman (HUN) faces headwinds from soft demand in specific markets and pricing pressures, it gains on actions to grow its downstream specialty and formulation businesses and synergies of acquisitions.

Zacks Equity Research

Huntsman (HUN) Gains on Downstream Expansion, Acquisitions

While Huntsman (HUN) faces headwinds from soft demand conditions, it benefits from investment in downstream businesses and differentiated product innovation as well as strategic acquisitions.

Zacks Equity Research

Huntsman (HUN) Unveils New Innovation Center in Belgium

The new 11,000-square-meter facility by Huntsman (HUN) includes a world-scale analytical laboratory, two machine halls and fully equipped and automated product testing areas.

Zacks Equity Research

Chemours (CC) Soars 5.5%: Is Further Upside Left in the Stock?

Chemours (CC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Equity Research

Why You Should Retain Huntsman (HUN) Stock in Your Portfolio

While Huntsman (HUN) faces headwinds from demand weakness in certain markets and pricing pressures, it benefits from actions to grow its downstream specialty and formulation businesses and synergies of acquisitions.

Zacks Equity Research

Huntsman's (HUN) Q1 Earnings Beat Estimates, Revenues Miss

Huntsman's (HUN) first-quarter earnings beat estimates while sales miss on lower average selling prices.